# Natural Antioxidants in the Treatment of Multiple Sclerosis

> **NCT00010842** · PHASE1,PHASE2 · COMPLETED · sponsor: **National Center for Complementary and Integrative Health (NCCIH)**

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Ginkgo biloba
- **DRUG:** Alpha-lipoic acid
- **DRUG:** Vitamin E/Selenium
- **DRUG:** Essential fatty acids

## Key facts

- **NCT ID:** NCT00010842
- **Lead sponsor:** National Center for Complementary and Integrative Health (NCCIH)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-09
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** — (—)
- **Last updated:** 2006-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00010842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00010842, "Natural Antioxidants in the Treatment of Multiple Sclerosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00010842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*